PRFX - Painreform Ltd
Painreform Ltd Logo

PRFX - Painreform Ltd

https://www.painreform.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System - PainReform ( NASDAQ:PRFX )
Benzinga • 1 month ago • score: 0.17
TEL AVIV, Israel, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- PainReform Ltd. PRFX, today announced, through its pharmaceutical division, the closing of its previously announced investment in LayerBio, Inc., a privately held Boston-based biotechnology company advancing sustained-release drug delivery ...
Bullish
PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio - PainReform ( NASDAQ:PRFX )
Benzinga • 2 months ago • score: 0.27
TEL AVIV, Israel, July 10, 2025 ( GLOBE NEWSWIRE ) -- PainReform Ltd. PRFX, today announced, through its pharmaceutical division, the signing of a strategic investment agreement with LayerBio Inc., a privately held Boston biotechnology company developing proprietary, long-acting, non-opiate ...
Bullish
PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market - PainReform ( NASDAQ:PRFX )
Benzinga • 5 months ago • score: 0.28
TEL AVIV, Israel, April 10, 2025 ( GLOBE NEWSWIRE ) -- PainReform Ltd. PRFX, a clinical-stage specialty pharmaceutical company and developer of AI-powered energy optimization technologies, today announced its official expansion into the rapidly growing Smart Energy Management ( SEM ) sector.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

PainReform Ltd., a pharmaceutical company specializing in clinical stages, is dedicated to the development of therapies that provide an extended period of post-surgical pain relief in Israel. The company is headquartered in Tel Aviv, Israel.

52W High
$16.63
52W Low
$1.25
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.57
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.32
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
1.57
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
9.62%
Institutions (25–75% balanced)
3.13%
Shares Outstanding
2,013,100
Float
1,340,800
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-32.16
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-3.22%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.0415
Previous
-0.0419
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025